Global Peptide Synthesis Market Size Study & Forecast, by Product (Equipment, Reagents & Consumables), Application (Therapeutics, Diagnosis), and Technology (Solid Phase Peptide Synthesis) and Regional Forecasts 2025-2035

The Global Peptide Synthesis Market is estimated at approximately USD 0.96 billion in 2024 and is poised to expand at a robust CAGR of 7.71% over the forecast period of 2025-2035. Peptide synthesis encompasses the generation of short chains of amino acids, which are foundational to therapeutic, diagnostic, and research applications. These peptides play a pivotal role in drug discovery, disease diagnostics, and biochemical research, acting as both functional molecules and building blocks for more complex biomolecules. The market growth is fueled by escalating demand for personalized medicine, rising prevalence of chronic diseases, and the increasing adoption of peptide-based therapeutics in clinical applications. Moreover, technological advancements in solid-phase peptide synthesis and automation are enhancing production efficiency and reducing time-to-market, further propelling market expansion.

The surge in pharmaceutical research and development activities has significantly augmented the demand for peptide synthesis solutions. Peptides are increasingly employed in therapeutic interventions, vaccine development, and diagnostic kits, making them indispensable for modern healthcare innovation. According to Statista, global pharmaceutical R&D spending surpassed USD 210 billion in 2023, signaling a sustained investment in advanced biomolecular tools, including peptide synthesis. Additionally, the expansion of biologics and peptide-based drug pipelines provides lucrative opportunities for market players. However, high production costs, stringent regulatory frameworks, and the emergence of alternative therapeutic modalities such as mRNA and gene therapies may present challenges that could temper market growth during the forecast period of 2025-2035.

Regional dynamics indicate that North America is expected to dominate the market throughout the forecast period, driven by well-established pharmaceutical infrastructure, extensive R&D capabilities, and widespread adoption of advanced synthesis technologies. Europe maintains a strong foothold due to the presence of leading biotech firms, governmental research grants, and robust healthcare frameworks. Meanwhile, the Asia Pacific region is projected to witness the fastest growth, fueled by escalating healthcare expenditure, rising prevalence of chronic and lifestyle-related diseases, and rapid industrialization in countries like China and India. Investments in research facilities, increasing clinical trials, and supportive governmental initiatives for biotechnology innovations further reinforce the region’s growth trajectory. Latin America and the Middle East & Africa are gradually expanding markets, supported by growing pharmaceutical investments and collaborations with global players.

Major market players included in this report are:
• Thermo Fisher Scientific Inc.
• Merck KGaA
• Lonza Group AG
• PolyPeptide Group
• PeptiDream Inc.
• Bachem Holding AG
• CordenPharma International
• CPC Scientific Inc.
• GenScript Biotech Corporation
• Wuxi AppTec Co., Ltd.
• AmbioPharm Inc.
• Peptone Ltd.
• Suzhou Canspec Scientific Co., Ltd.
• Apeptide Co., Ltd.
• JPT Peptide Technologies GmbH

Global Peptide Synthesis Market Report Scope:
• Historical Data – 2023, 2024
• Base Year for Estimation – 2024
• Forecast period - 2025-2035
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa



The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players.

By Product:
• Equipment
• Reagents & Consumables

By Application:
• Therapeutics
• Diagnosis

By Technology:
• Solid Phase Peptide Synthesis

By End-use:
• Pharmaceuticals & Biotechnology Companies
• Research Laboratories
• Academic & Clinical Research Institutes

By Region:

North America
• U.S.
• Canada

Europe
• UK
• Germany
• France
• Spain
• Italy
• Rest of Europe

Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• Rest of APAC

Latin America
• Brazil
• Mexico

Middle East & Africa
• UAE
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Key Takeaways:
• Market Estimates & Forecast for 10 years from 2025 to 2035.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions. Show more